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Explantation of infected thoracic endovascular aortic repair
Emily Y. Fan, BA,a Dejah R. Judelson, MD,b and Andres Schanzer, MD,b Worcester, Mass
ABSTRACT
Prosthetic graft infection is a rare and serious complication of thoracic endovascular aortic repair associated with high
mortality and posing unique challenges for treatment. The prosthetic graft infection is often identiﬁed late as patients
present with mild nonspeciﬁc symptoms. We describe the successful medical management and surgical explantation of
an infected thoracic endograft with an aorta-bronchial ﬁstula, using an inline reconstruction with an antibiotic-soaked
synthetic graft. In this report, we provide an example of a patient with an infected thoracic endograft and how inline
reconstruction combinedwith appropriatemedical management is an acceptable treatment strategy. (J Vasc Surg Cases
and Innovative Techniques 2018;4:307-10.)
Thoracic endovascular aortic repair (TEVAR) is the
accepted standard treatment strategy for adults present-
ing with blunt thoracic aortic injury (BTAI).1,2 Multiple
studies have validated reduced morbidity and mortality
of TEVAR compared with open repair.1-3 With the
evolution of TEVAR devices designed speciﬁcally for
BTAI and multidisciplinary guidelines4 recommending
TEVAR as the treatment of choice, reports have docu-
mented improved overall survival as well as decreased
rates of device-related complications in applying TEVAR
for BTAI.5
Endoleaks, device infection, and acute thrombosis have
all been reported as rare complications from TEVAR.6,7
Infection is often discovered late, following prolonged
fevers of unknown origin, and can be associated with
aorta-esophageal or aorta-bronchial ﬁstulas. Whereas
the incidence of graft infection after endovascular aneu-
rysm repair has been studied extensively and docu-
mented to occur in the range of 0.16% to 1.37%,8,9 the
incidence of graft infection after TEVAR is less certain
because of the relative rarity of this condition and is esti-
mated to be approximately 1.7%.10 Although both medi-
cal and surgical management of TEVAR graft infections
have been described,11-13 there is no consensus on the
standard of care.
This report describes the successful treatment of a
TEVAR graft infection, secondary to an aorta-bronchial
ﬁstula, that presented 17 years after the index repair.
The patient provided consent to have this case
published.
CASE REPORT
A 45-year-oldman presented 17 years after a high-speedmotor
vehicle accident inwhichhe sustainedmultiple injuries including
a BTAI with near aortic transection (grade 3).14 He underwent an
exploratory laparotomywith splenectomy and repair of a bladder
injury. Because of his overall health, he was deemed at too high
risk for a thoracotomy, so his aortic repair was performed with a
compassionate use Gore TAG Endoprosthesis (W. L. Gore & Asso-
ciates, Flagstaff, Ariz) measuring 26 mm  7 cm with bilateral
femoral cutdowns. The injury was 2.5 cm from the left subclavian
artery; there was partial inadvertent coverage of the left subcla-
vian artery with only 8 mm Hg of blood pressure difference
between the arms. Several years later, he had thrombosis of the
left subclavian artery that required a stent graft at the origin of
the left subclavian artery.
Unfortunately, he was lost to follow-up after 3 years of surveil-
lance. Eight months before his current presentation, he was
evaluated at an outside hospital for a 1-week history of fever,
chills, and malaise; he completed an outpatient course of
Fig 1. Air between the endograft and native wall of the
aorta (arrow) and a vegetation adhering to the aortic
endograft (star) are demonstrated on a preoperative axial
computed tomography angiography scan.
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antibiotics for pneumonia. Two months later, he presented
again with prolonged fevers and chills with Streptococcus
viridans and Mycoplasma bacteremia that was treated with an
inpatient course of parenteral antibiotics. During the subse-
quent 6 months, he continued to have intermittent fevers and
a 30-pound weight loss. He presented to our institution with
high fevers and sepsis from Staphylococcus capitis bacteremia
and was admitted to the intensive care unit. Transthoracic
echocardiography revealed two freely mobile pedunculated
vegetations within the thoracic aortic endograft, the largest
measuring 1 cm without evidence of valvular vegetations.
Computed tomography angiography of the chest revealed a
right lower lobe consolidation with collapse and bilateral pleural
effusions. The thoracic aortic endograft extended from the
aortic arch, abutting the left subclavian stent graft. The native
aortic wall around the stent graft was diffusely thickened with
several foci of air between the graft and the native wall of the
aorta (Fig 1).
We proceeded with an open surgical explantation of the aortic
endograft and left subclavian artery stent graft, aortic débride-
ment, and inline reconstruction with a rifampin antibiotic-
soaked prefabricated Dacron graft. Other considered options
included extra-anatomic bypass with an axillobifemoral bypass
(given his young age, we were concerned about the decreased
long-term patency with this approach)15 and reconstruction
with cryopreserved aorta (an adequate size match for his
thoracic aorta was not available).
The chest was entered through a left posterolateral thoracot-
omy at the fourth intercostal space. Dense adhesions between
the left upper lobe of the lung and the aortic wall were
dissected, revealing a focal abscess that penetrated the aortic
wall to the fabric of the endograft, consistent with an aortopul-
monary ﬁstula (Fig 2, A). A wedge resection of this portion of
involved lung was performed using a 60-mm TA stapler (Covi-
dien, Mansﬁeld, Mass). Under hypothermic circulatory arrest
down to 16.3C, the aortic endograft (Fig 2, B and C), left subcla-
vian artery stent graft, and proximal descending thoracic aorta
(Fig 2, D) were all excised with wide débridement. Inline
anatomic reconstruction of the aorta was performed using a
24-mm rifampin-soaked Dacron graft, as previously described
(Fig 3).16 There was no tissue coverage. The patient was extu-
bated with no immediate complications.
Intraoperative cultures from the endograft, aortic wall, and veg-
etations grew Candida. With consultation of our infectious dis-
ease colleagues, he was initiated on lifelong oral antifungal
(ﬂuconazole) therapy and a short course of broad-spectrum
antibiotics. His postoperative course was complicated by a
Fig 2. A, Intraoperative resection of aorta-bronchial ﬁstula between the left upper lobe of the lung and the
aortic endograft. B and C, Excised aortic endograft with an intraluminal vegetation. D, Portion of the excised
infected native descending thoracic aorta.
Fig 3. Inline anatomic reconstruction of the descending
thoracic aorta with a rifampin antibiotic-soaked Dacron
graft.
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chylothorax, which was initially managed with total parenteral
nutrition but ultimately required coil embolization and Onyx
glue (ev3, Covidien, Plymouth, Minn) obliteration of the thoracic
duct (Fig 4, A and B). He was discharged home on postoperative
day 11. At 2months, computed tomography angiographydemon-
strated a patent repair andno evidence of infection (Fig 4, C). He is
still doing well at his 6-month postoperative check.
DISCUSSION
As TEVAR continues to become more commonplace in
younger patients, managing complications of these
endografts will become increasingly important. We
describe the treatment of an infected endograft 17 years
after TEVAR for a BTAI. Patients who require explantation
because of infection have poorer outcomes than those
with endoleaks or inadequate aneurysm exclusion
because of underlying sepsis and the extent of resection
required.17 Mortality rates have been reported to be as
high as 83% to 100% at 2 months for those treated
with medical management only,12,18 whereas the addi-
tion of surgical explantation has been shown to have
an overall 5-year survival of 51%.18 Infections of thoracic
endografts are difﬁcult to manage because the source
is often discovered late if at all. Most patients present
with prolonged fevers of unknown origin, weight loss,
or general malaise. In addition, thoracic graft infections
are often associated with ﬁstula to an adjacent organ
(as in this case, the lung) that is not identiﬁed until the
time of surgery, which can lead to even higher mortality.
Surgical excision of all prosthetic material with wide
débridement remains the “gold standard” treatment.
Aortic reconstruction can be performed in situ using
prosthetic grafts, cryopreserved arterial allografts, or an
extra-anatomic bypass. We used an inline reconstruction
with a rifampin-soaked graft after wide débridement.
Previous studies have demonstrated excellent results
using antibiotic-soaked grafts, with studies reporting
low rates of reinfection and excellent graft patency.19
A key adjunct for this surgical approach is for early
medical management targeted toward the speciﬁc
pathogen causing the infection. Identifying the source
of infection in a timely manner is critically important.
This patient had recent bacteremia that never fully
resolved, associated with a pneumonia that caused par-
tial lung collapse, pleural effusions, and an aorta-
bronchial ﬁstula that eroded into the endograft. He was
started on broad-spectrum antibiotics immediately
after admission, and the regimen was later tailored to
the microbiology results; now he is receiving lifelong
antifungal therapy.
Our case was complicated by a postoperative chylo-
thorax, a rare but serious injury. The reported incidence
of thoracic duct injuries ranges from 0.5% to 2%.20 It
can lead to nutritional deﬁciencies, respiratory dysfunc-
tion, and immunosuppression with a mortality rate of
up to 50%.21 Whereas conservative management has
been reported with low-fat diets or drainage by chest
tubes, the overall failure rate is high, and more than
half will require surgical intervention later.22 His chylo-
thorax was treated by direct cannulation of the cisterna
chyli and deﬁnitive coiling of the thoracic duct. His
chest tube output ceased immediately after this pro-
cedure and did not recur after normal diet was
reinitiated.
CONCLUSIONS
The treatment of infected thoracic endografts is chal-
lenging and associated with high morbidity and mortal-
ity. With prompt detection of infection and aggressive
surgical treatment with appropriate antibiotic therapy,
Fig 4. Postoperative chylothorax secondary to thoracic duct disruption (A) that was treated successfully with
percutaneous coil embolization and Onyx glue (B). C, Reconstruction image obtained 2months postoperatively
demonstrates thoracic aorta with excellent patency.
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they can be successfully managed. Complete long-term
freedom from reinfection remains unclear and requires
lifelong imaging surveillance.
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